Abstract:Objective The diminished expression of microRNA-146a (miR-146a) in systemic lupus erythematosus (SLE) contributes to the aberrant activation of the interferon pathway. Despite its significance, the underlying mechanism driving this reduced expression remains elusive. Considering the integral role of enhancers in steering gene expression, our study seeks to pinpoint the SLE-affected enhancers responsible for modulating miR-146a expression. Additionally, we aim to elucidate the mechanisms by which these enhancers influence the contribution of miR-146a to the activation of the interferon pathway.Methods Circular chromosome conformation capture sequencing and epigenomic profiles were applied to identify candidate enhancers of miR-146a. CRISPR activation was performed to screen functional enhancers. Differential analysis of chromatin accessibility was used to identify SLE-dysregulated enhancers, and the mechanism underlying enhancer dysfunction was investigated by analyzing transcription factor binding. The therapeutic value of a lupus-related enhancer was further evaluated by targeting it in the peripheral blood mononuclear cells (PBMCs) of patients with SLE through a CRISPR activation approach.Results We identified shared and cell-specific enhancers of miR-146a in distinct immune cells. An enhancer 32.5 kb downstream of miR-146a possesses less accessibility in SLE, and its chromatin openness was negatively correlated with SLE disease activity. Moreover, CCAAT/enhancer binding protein alpha, a down-regulated transcription factor in patients with SLE, binds to the 32.5-kb enhancer and induces the epigenomic change of this locus. Furthermore, CRISPR-based activation of this enhancer in SLE PBMCs could inhibit the activity of interferon pathway.Conclusion Our work defines a promising target for SLE intervention. We adopted integrative approaches to define cell-specific and functional enhancers of the SLE critical gene and investigated the mechanism underlying its dysregulation mediated by a lupus-related enhancer. imageConclusionOur work defines a promising target for SLE intervention. We adopted integrative approaches to define cell-specific and functional enhancers of the SLE critical gene and investigated the mechanism underlying its dysregulation mediated by a lupus-related enhancer. image

The Lupus Autoantigen La Prevents Mis-channeling of tRNA Fragments into the Human MicroRNA Pathway

Analysis of Microrna-199A-3p Expression in CD4 + T Cells of Systemic Lupus Erythematosus

Autoantigen La Promotes Efficient RNAi, Antiviral Response, and Transposon Silencing by Facilitating Multiple-Turnover RISC Catalysis

La proteins couple use of sequence-specific and non-specific binding modes to engage RNA substrates

Analysis of the interaction with the hepatitis C virus mRNA reveals an alternative mode of RNA recognition by the human La protein

A -variant reveals a Pol III transcriptome response dependent on La protein/SSB

A Telomerase Subunit Homolog La Protein from Trypanosoma Brucei Plays an Essential Role in Ribosomal Biogenesis

A POLR3B-variant reveals a Pol III transcriptome response dependent on La protein/SSB

LncRNA Malat1 inhibition of TDP43 cleavage suppresses IRF3-initiated antiviral innate immunity

Dysregulation of Trna-Derived Small RNAs and Their Potential Roles in Lupus Nephritis

MicroRNA-146A Contributes to Abnormal Activation of the Type I Interferon Pathway in Human Lupus by Targeting the Key Signaling Proteins.

Alternatively spliced isoforms of AUF1 regulate a miRNA–mRNA interaction differentially through their YGG motif

In vivo, Argonaute-bound microRNAs exist predominantly in a reservoir of low molecular weight complexes not associated with mRNA

Nuclear trafficking of La protein depends on a newly identified nucleolar localization signal and the ability to bind RNA

Three-Dimensional Chromosomal Landscape Revealing Mir-146A Dysfunctional Enhancer in Lupus and Establishing a CRISPR-Mediated Approach to Inhibit the Interferon Pathway

Human antigen R transfers miRNA to Syntaxin 5 to synergize miRNA export from activated macrophages

Antagonizing Mir-7 Suppresses B Cell Hyperresponsiveness and Inhibits Lupus Development.

MiR-574-5p activates human TLR8 to promote autoimmune signaling and lupus

Inhibition of miRNA associated with a disease-specific signature and secreted via extracellular vesicles of systemic lupus erythematosus patients suppresses target organ inflammation in a humanized mouse model

iTreg cells-secreted IL10 alleviates lupus nephritis through inactivating lncRNA HAR1A transcription to suppress SMARCD1-mediated iNOS activation

Interaction between a J-domain co-chaperone and a specific Argonaute protein contributes to microRNA function in animals